208 related articles for article (PubMed ID: 32692242)
1. Long-term hydroxychloroquine therapy improves the quality of sleep in patients with primary Sjögren's syndrome: a real-world study.
Guan P; Sun C; Chen Z; Chen J; Ran R
Ann Palliat Med; 2020 Jul; 9(4):2203-2210. PubMed ID: 32692242
[TBL] [Abstract][Full Text] [Related]
2. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Oral Hydroxychloroquine in the Treatment of Ophthalmic Disease Associated with Sjögren's Syndrome.
Fang W; Qingqing Z; Qihui L; Bing Z; Xinyue H; Jie X
Altern Ther Health Med; 2023 Nov; 29(8):656-662. PubMed ID: 37678871
[TBL] [Abstract][Full Text] [Related]
4. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.
Wang SQ; Zhang LW; Wei P; Hua H
BMC Musculoskelet Disord; 2017 May; 18(1):186. PubMed ID: 28499370
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine.
Collins A; Lendrem D; Wason J; Tarn J; Howard-Tripp N; Bodewes I; Versnel MA; Gottenberg JE; Seror R; Mariette X; Ng WF
Rheumatol Int; 2021 Sep; 41(9):1593-1600. PubMed ID: 34165604
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, correlates, and impact of sleep disturbance in Chinese patients with primary Sjögren's syndrome.
Cui Y; Li J; Li L; Zhao Q; Chen S; Xia L; Fu T; Ji J; Gu Z
Int J Rheum Dis; 2020 Mar; 23(3):367-373. PubMed ID: 31763772
[TBL] [Abstract][Full Text] [Related]
7. Impact of sleep quality on clinical features of primary Sjögren's syndrome.
Chung SW; Hur J; Ha YJ; Kang EH; Hyon JY; Lee HJ; Song YW; Lee YJ
Korean J Intern Med; 2019 Sep; 34(5):1154-1164. PubMed ID: 29458245
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of sleep disturbance and related factors in patients with primary Sjögren's syndrome].
Wang YF; Fan Z; Cheng YB; Jin YB; Huo Y; He J
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1063-1068. PubMed ID: 33331314
[TBL] [Abstract][Full Text] [Related]
9. A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.
Bai W; Yang F; Xu H; Wei W; Li H; Zhang L; Zhao Y; Shi X; Zhang Y; Zeng X; Leng X
Trials; 2023 Feb; 24(1):112. PubMed ID: 36793118
[TBL] [Abstract][Full Text] [Related]
10. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
[TBL] [Abstract][Full Text] [Related]
11. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
[TBL] [Abstract][Full Text] [Related]
12. The association between hydroxychloroquine use and future development of systemic lupus erythematosus in patients with primary Sjögren's syndrome.
Hsu BC; Chen YH; Lin CH; Tang KT
Int J Rheum Dis; 2022 Dec; 25(12):1424-1430. PubMed ID: 36089698
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Iguratimod in Treating Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
Pu J; Wang X; Riaz F; Zhang T; Gao R; Pan S; Wu Z; Liang Y; Zhuang S; Tang J
Front Pharmacol; 2021; 12():621208. PubMed ID: 33815105
[No Abstract] [Full Text] [Related]
14. Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review.
Zhang A; Chen S; Lin R
Immun Inflamm Dis; 2023 Oct; 11(10):e1044. PubMed ID: 37904705
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome.
Yavuz S; Asfuroğlu E; Bicakcigil M; Toker E
Rheumatol Int; 2011 Aug; 31(8):1045-9. PubMed ID: 20309693
[TBL] [Abstract][Full Text] [Related]
16. Assessment of hydroxychloroquine blood levels in Sjögren's disease patients: drug adherence and clinical associations.
Pasoto SG; Villamarín LEB; de Vinci Kanda Kupa L; Deveza GBH; Ribeiro CT; Emi Aikawa N; Leon EP; de Oliveira Martins VA; Silva CA; Bonfa E
Rheumatol Int; 2024 Jul; 44(7):1305-1315. PubMed ID: 38294544
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren's syndrome in the JOQUER randomized trial.
Bodewes ILA; Gottenberg JE; van Helden-Meeuwsen CG; Mariette X; Versnel MA
Rheumatology (Oxford); 2020 Jan; 59(1):107-111. PubMed ID: 31237947
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and mechanism for action of iguratimod in primary Sjögren's syndrome patients.
Jiang W; Zhang L; Zhao Y; He X; Hu C; Liu Y
Int Ophthalmol; 2020 Nov; 40(11):3059-3065. PubMed ID: 32607949
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the efficacy and safety of herbal decoction CheReCunJin alone and combined with hydroxychloroquine for treating primary Sjögren's syndrome: A randomized controlled trial.
Shao Q; Jin L; Li C; Wang J; Wang M; Wang Q; Wu B
Explore (NY); 2022; 18(4):416-422. PubMed ID: 34417112
[TBL] [Abstract][Full Text] [Related]
20. Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study.
Yoon CH; Lee HJ; Lee EY; Lee EB; Lee WW; Kim MK; Wee WR
J Korean Med Sci; 2016 Jul; 31(7):1127-35. PubMed ID: 27366013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
